Thank you.
I am also accompanied by colleagues, Dr. Natasha Crowcroft, vice-president, infectious diseases and vaccination program branch; Stephen Bent, vice-president of regulatory, operations and emergency management branch; and Rod Greenough, our agency's chief financial officer.
It is an honour to be here to speak to some recent items included under supplementary estimates (B), as well as current key areas of focus within the Public Health Agency of Canada, or PHAC.
Before I touch on the items in the supplementary estimates, I would like to take a moment to recognize and thank the outstanding team of dedicated professionals I have the privilege of working with at the Public Health Agency of Canada. Every day, our agency colleagues demonstrate an unwavering commitment to public health and public service that drives our work forward to secure the health and well-being for all people in Canada.
PHAC is seeking a total of $67.5 million through the supplementary estimates (B). Highlights include funding of $47.6 million for pandemic vaccine preparedness, specifically the procurement of AS‑03 adjuvant, a critical ingredient for the pandemic influenza vaccine.
This funding will strengthen Canada’s pandemic readiness posture and security of supply, protecting the health and safety of Canadians through timely access to vaccines in the event of an influenza pandemic.
Additionally, these estimates include one funding re-profile totalling $16.9 million, which supports the strategic priorities and long-term capital planning undertaken by the National Aboriginal Head Start Association of Canada. Shifting this funding into 2025-26 is critical to ensure uninterrupted delivery of high-quality, culturally responsive early learning programming for indigenous children living off-reserve in urban and northern communities, and to support implementation of the association’s long-term capital plan.
These investments through the supplementary estimates, however, represent only a small portion of the agency’s important work.
The proposed spending will support a strong public health system that contributes to Canada’s economic and national security.
PHAC's focus is to ensure a strong defence against a wide range of public health threats.
PHAC plays an important health security role for emergency preparedness, more broadly, including to chemical, biological or nuclear incidents, or natural disasters with health consequences.
Recognizing the contribution of resilience to overall well-being, PHAC is also supporting innovative community-based intervention projects in over 200 communities.
From our world-class and highly specialized laboratory facilities to our capabilities to detect, understand and act on public health threats, the Public Health Agency of Canada collaborates closely with provinces, territories and indigenous partners to prevent, prepare for and respond in real time to public health events. While we fulfill an important federal role, we do so with strong community engagement to foster trust in public health and be responsive to the diversity of needs across the country through a health equity-driven approach grounded in the best available scientific evidence and data to guide action.
Mr. Chair, it is a privilege for my colleagues and me to appear before this committee and to respond to your questions on the work we are doing to safeguard the health of Canadians.
Thank you.